ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nebraska » Specialist

Top Specialist Prescribers in Nebraska

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KELLI BREMER M.D.

Specialist

587

$89.2K

100
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$152
Average prescription price

Avg: $95

KAVIR SAXENA MD

Specialist

3,135

$481K

192
51 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$153
Average prescription price

Avg: $95

EVA BRION MD

Specialist

3,921

$724K

140
32 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 26%

$185
Average prescription price

Avg: $95

PAUL NELSON MD

Specialist

8,520

$369K

357
308 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $95

RICHARD KOEFOOT M.D.

Specialist

1,273

$59K

357
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $95

LARRY SIREF M.D.

Specialist

2,088

$132K

358
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $95

MATTHEW HRNICEK MD

Specialist

950

$111K

308
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $95

GARY VARILEK MD

Specialist

1,294

$187K

363
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 26%

$145
Average prescription price

Avg: $95

MICHAEL SULLIVAN M.D.

Specialist

1,147

$139K

184
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 26%

$121
Average prescription price

Avg: $95

RICK WINDLE M.D.

Specialist

94

$1,417

65
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

82%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 26%

$15
Average prescription price

Avg: $95

MARK GRIFFIN MD

Specialist

2,198

$369K

512
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 26%

$168
Average prescription price

Avg: $95

JAMES MORGAN MD

Specialist

2,460

$136K

269
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $95

ZEYAD MORCOS MD

Specialist

1,836

$375K

318
156 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$204
Average prescription price

Avg: $95

DONALD BELL MD

Specialist

186

$6,546

54
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

41%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $95

PAUL PETERSEN MD

Specialist

724

$99.5K

259
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 26%

$137
Average prescription price

Avg: $95

LORI REED M.D.

Specialist

173

$3,774

48
18 are 65+

35%
patients receiving schedule two controlled substances

Avg: 2%

52%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 26%

$22
Average prescription price

Avg: $95

HERMAN GREENWALD M.D.

Specialist

1,704

$43.7K

281
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 26%

$26
Average prescription price

Avg: $95

DOUGLAS POPE M.D.

Specialist

3,670

$271K

238
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$74
Average prescription price

Avg: $95

KIRK KINBERG M.D.

Specialist

674

$70.7K

133
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 26%

$105
Average prescription price

Avg: $95

ANDREW COEN MD

Specialist

1,771

$184K

402
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$104
Average prescription price

Avg: $95

STEVEN DUNDER M.D.

Specialist

994

$245K

154
134 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 26%

$247
Average prescription price

Avg: $95

DAVID KINGSLEY M.D.

Specialist

1,229

$46K

385
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $95

WALLACE DUFF, M.D.

Specialist

2,642

$95.6K

441
378 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $95

DAVID SAMANI M.D.

Specialist

338

$11.6K

91
56 are 65+

27%
patients receiving schedule two controlled substances

Avg: 2%

45%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

4%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $95

FREDERIC KIECHEL M.D.

Specialist

942

$126K

163
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 26%

$134
Average prescription price

Avg: $95

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank